CD274 and neoplasm: PD-L1 is generally regulated by tumor cells in two ways: the first is innate immune resistance in which constitutive oncogenic signaling is correlated with PD-L1 expression, the second is an adaptive immune resistance through which IFN-γ produced by TILs induces PD-L1 expression.